|
LSS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.29070087950822E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.93982673946903E-13 |
| Normal-vs-Stage2 |
1.80120000026207E-08 |
| Normal-vs-Stage3 |
2.816600E-01 |
| Normal-vs-Stage4 |
2.6512003703516E-10 |
| Stage1-vs-Stage2 |
7.148400E-01 |
| Stage1-vs-Stage3 |
2.078800E-01 |
| Stage1-vs-Stage4 |
7.417500E-02 |
| Stage2-vs-Stage3 |
1.674820E-01 |
| Stage2-vs-Stage4 |
8.350300E-02 |
| Stage3-vs-Stage4 |
2.417600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.64464055894132E-12 |
| Normal-vs-AfricanAmerican |
5.39279999989262E-07 |
| Normal-vs-Asian |
8.488300E-02 |
| Caucasian-vs-AfricanAmerican |
8.091000E-01 |
| Caucasian-vs-Asian |
9.141000E-01 |
| AfricanAmerican-vs-Asian |
8.506600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.36939373571477E-12 |
| Normal-vs-Female |
2.68160000005402E-06 |
| Male-vs-Female |
2.262000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.034250E-04 |
| Normal-vs-Extreme_Weight |
1.00029999838824E-08 |
| Normal-vs-Obese |
2.15329998276559E-09 |
| Normal-vs-Extreme_Obese |
2.230800E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.673600E-01 |
| Normal_Weight-vs-Obese |
7.474800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.229000E-01 |
| Extreme_Weight-vs-Obese |
5.629400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.576000E-01 |
| Obese-vs-Extreme_Obese |
6.371000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.301500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.45259999981573E-07 |
| Normal-vs-Age(61-80Yrs) |
1.34725564038263E-12 |
| Normal-vs-Age(81-100Yrs) |
1.48099998931173E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.683000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.136400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.568600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.744000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.032200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.119820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.69544411632705E-14 |
| Normal-VS-Type2 PRCC |
5.836500E-03 |
| Normal-VS-KIRP CIMP |
2.37859999999701E-05 |
| Normal-VS-Unclassified PRCC |
5.121700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.601900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.080000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.644000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.386600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.991800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.566000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.587860E-02 |
| Normal-vs-N1 |
1.56730000000493E-06 |
| Normal-vs-N2 |
3.251400000015E-06 |
| N0-vs-N1 |
4.600400E-01 |
| N0-vs-N2 |
4.296600E-01 |
| N1-vs-N2 |
1.784840E-01 |
|
|
